Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. (Q48489376)
scientific article published in September 2002
Language:
Current Data About Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
(P31) (Q13442814)
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P304) 679-687
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P407) (Q1860)

(P433) 5
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P478) 59
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P577) Sunday, September 1, 2002
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P1433) (Q1161692)
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P1476) "Benefit of interferon beta-1a on MSFC progression in secondary progressive MS." (language: en)
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

(P2093) J A Cohen
(P1545) 1
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

G R Cutter
(P1545) 2
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

J S Fischer
(P1545) 3
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

A D Goodman
(P1545) 4
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

F R Heidenreich
(P1545) 5
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

M F Kooijmans
(P1545) 6
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

A W Sandrock
(P1545) 7
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

R A Rudick
(P1545) 8
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

J H Simon
(P1545) 9
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

N A Simonian
(P1545) 10
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

E C Tsao
(P1545) 11
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

J N Whitaker
(P1545) 12
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

IMPACT Investigators
(P1545) 13
(P248)
(P698) 12221157
(P813) Monday, February 12, 2018
(P854) http://europepmc.org/abstract/MED/12221157

other details
description scientific article published in September 2002

External Links
(P356) 10.1212/WNL.59.5.679
(P698) 12221157